Further Information:
The Health Products Regulatory Authority has been notified of a shortage of the following products:
- Aripiprazole Teva 5mg Tablet – PA1986/019/001
- Aripiprazole Teva 10mg Tablet – PA1986/019/002
- Cellcept 500mg Solution for Infusion – EU/1/96/005/005
- Innohep 4500IU Solution for Injection – PA0046/060/007
- Isoptin 40mg Film Coated Tablet – PA2010/003/001
- Metformin Bluefish 500mg Film Coated Tablet – PA1436/009/001
- Rifadin 100mg/5ml Oral Suspension – PA0540/066/004
The following shortages have been resolved and supply has resumed to the Irish market:
- Anapen 150mcg Solution for Injeciton in Prefilled Syringe – PA22580/001/001
- Buplex Rx 400mg Tablet – PA1380/088/002
- Ciprofloxacin 250mg Tablet – PA0749/031/002
- Ezetimibe Teva 10mg Tablet – PA1986/012/001
- Kemadrin 5mg Tablet – PA1691/005/001
- Inspra 50mg Film Coated Tablet – PA0822/020/002
- Nexium Control 20mg Tablet – EU/1/13/860/001-002
- Parox 10mg Film Coated Tablet – PA0711/052/002
- Rifinah 300mg/150mg Tablet – PA0540/068/002
- Spectrila 10,000IU Powder and Solvent for Solution for Injection/Infusion – EU/1/15/1072/001-002
- Yazmin 0.03mg/3mg Film Coated Tablet – PA1410/023/001
Please see the shortages section of the HPRA website for further information.
The HPRA will be sending weekly updates concerning medicinal product shortages. However, the above webpage will be updated as new information is provided to the HPRA.